In SURPASS-2, which compared tirzepatide to semaglutide (a GLP-1 receptor agonist) in patients taking metformin, tirzepatide 5 mg, 10 mg, and 15 mg doses achieved mean HbA1c reductions of 2.01%, 2.24%, and 2.30% respectively from baseline, compared to 1.86% with semaglutide 1 mg
Applications for post-viral syndromes (COVID19) The COVID-19 pandemic introduced novel health challenges, including the management of post-viral syndromes like long COVID. Long COVID is defined as an infection-associated chronic condition that occurs after SARS-CoV-2 infection and is present for at least 3 months as a continuous, relapsing and remitting, or progressive disease state that affects one or more organ systems
Step 1: Track your protein intake
THE DISH ON GLP-1 Sponsored by Advanced Herbals, from the makers of Dramamine, and Fleet Feeling nauseous or constipated are often first clues that something isnt right
Theoretical and Class-Level Risks These have not been confirmed in cagrilintide trials but are flagged because they appear in related amylin or GLP-1 class data: pancreatitis, gallbladder disease, severe hypoglycemia (mainly when combined with insulin or sulfonylureas), and acute kidney injury secondary to dehydration from severe nausea or vomiting
Adv Exp Med Biol 136, B86579
